BRIEF published on 03/14/2024 at 19:05, 9 months 7 days ago Ortho Development Receives FDA Clearance on Trivicta Hip System FDA Clearance Orthopedic Surgery Ortho Development Trivicta Hip System Hip Replacement
PRESS RELEASE published on 03/14/2024 at 19:00, 9 months 7 days ago Ortho Development Receives FDA Clearance on Trivicta Hip System Ortho Development Corporation announces FDA clearance of Trivicta Hip System, a versatile orthopedic implant designed for hip joint replacement surgery, offering triple-taper femoral stem for optimal fit FDA Clearance Orthopedic Implants Trivicta Hip System Ortho Development Corporation Hip Joint Replacement Surgery
Published on 12/21/2024 at 01:30, 18 hours ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 25 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 20 hours ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 39 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 45 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 7 hours 12 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days 1 hour ago Share capital decrease by way of treasury shares cancellation
